Category: Uncategorized

What Crystals Are Used in Nuclear Medicine?

Crystals are an essential component of nuclear medicine imaging systems, and manufacturers use several different types of crystals to capture and power the cameras. With the number of options in the market, it’s easy to become overwhelmed by all the choices. This post reviews the primary crystals used in nuclear

Read More »

What You Need to Know About the Change to the Stark Law

After years of discussion, negotiation, and delays, sweeping changes to the Physician Self-Referral Law, or as it’s commonly known – Stark Law, took effect earlier this year. While the passage of the original bill was met with resistance, these updates were intended to clarify and modernize components of the law

Read More »

What the Appropriate Use Mandate Delay Means for Imaging Providers

Last month, the Centers for Medicare and Medicaid Services (CMS) announced that the Medicare Appropriate Use Criteria Program deadline had been extended yet again. Originally slated to take effect on January 1, 2021, the new deadline extends the start date by a full year. The rules and reimbursement guidance was

Read More »

When and How Does Nuclear Medicine Go Back to Normal?

The entire medical system of the United States has been focused on a single threat over the past eight weeks. While the dangers from COVID-19 remain present, many states are beginning to open back up, and as capacity increases, medical facilities are easing back into seeing patients. Along with the

Read More »

Top 5 Posts from the Digirad blog in 2018

Digirad’s blog provides a variety of resources that keep you up to date on the ever-changing healthcare industry, including the advancements and issues that directly impact the operation of your practice. As we kick off a new year, here’s a look back at Digirad’s Top 5 Blog Posts from 2018:

Read More »

Why you should rethink PET/CT imaging for prostate cancer

The large majority of the nuclear imaging community would be quick to point out that PET/CT imaging with either 18Fluorodeoxyglucose (18FDG), or Sodium 18Fluoride (NaF18), is not effective in prostate cancer diagnosis. In fact, it’s not even approved for initial prostate treatment strategy. With oncology imaging, most other cancers are

Read More »

Search

Categories
Making Healthcare Convenient. As Needed. When Needed. Where Needed.

Sign Up!

Subscribe to the Digirad Newsletter for the latest updates.

©2021 Digirad Corporation. All rights reserved.